Clinical Trials Browser

Phase 3 × belantamab mafodotin × 1 year × Clear all

NCT04162210 2026-02-11

DREAMM-3

Phase 3 Active not recruiting

325 enrolled 10 charts

Multiple Myeloma

NCT06679101 2026-01-08

DREAMM-10

Phase 3 Recruiting

Multiple Myeloma

NCT07285239 2025-12-16

PrE1005

Phase 3 Not yet recruiting

Multiple Myeloma

NCT06956170 2025-06-11

DREAMM 8

Phase 3 Active not recruiting

21 enrolled 9 charts

Multiple Myeloma

NCT06868667 2025-05-09

DREAMM 7

Phase 3 Active not recruiting

24 enrolled 10 charts

Multiple Myeloma